R Ashok comes under criticism for disrespect to Supreme Court order regarding Patanjali
Bengaluru: The leader of the opposition, R Ashok, has come under criticism for his reaction to Health Minister Dinesh Gundu Rao's statement regarding Patanjali's medicines. Following the Supreme Court's concerns about the quality of Patanjali products, the state government has been instructed to conduct quality testing of these medicines.
In a post on social media platform X, R Ashok criticized the Congress government, accusing it of targeting Patanjali, which he claims is a favorite brand among Indians. He accused the government of displaying bias against Hindu organizations and businesses, suggesting that the Congress party's politics of hatred will lead to its downfall.
Dinesh Gundurao, the Health Minister, stated in Bengaluru that the state government has instructed testing of Patanjali medicines due to misleading marketing practices by the organization. He emphasized that it is unethical to promote products without scientific evidence and that the Supreme Court has expressed serious concerns regarding Patanjali's claims.
The Supreme Court had previously expressed dissatisfaction with an apology issued by Patanjali's founders, stating that mere apologies are not sufficient and that actions must be taken to rectify the wrongdoing.
R Ashok's defense of Patanjali and Baba Ramdev, despite the Supreme Court's stance, has raised eyebrows. His apparent disregard for the Supreme Court's order has led to questions about his allegiance to Patanjali and Baba Ramdev, especially considering his political affiliations with the BJP.
ಈ ಹಲಾಲ್ ಕಟ್ @INCKarnataka ಸರ್ಕಾರ ಹಿಂದೂಗಳು, ಹಿಂದೂಗಳ ಸಂಸ್ಥೆಗಳು, ಬಿಸಿನೆಸ್ ಗಳು ಬೆಳೆದರೆ ಸಹಿಸೋದೇ ಇಲ್ಲ.
— R. Ashoka (ಮೋದಿ ಅವರ ಕುಟುಂಬ) (@RAshokaBJP) April 12, 2024
ಸಮಸ್ತ ಭಾರತೀಯರ ಅಚ್ಚುಮೆಚ್ಚಿನ ಬ್ರ್ಯಾಂಡ್ ಆಗಿ ಬೆಳೆಯುತ್ತಿರುವ ಬಾಬಾ ರಾಮದೇವ್ ಅವರ ಪತಂಜಲಿ ಮೇಲೆ ಈಗ ಕಾಂಗ್ರೆಸ್ ಸರ್ಕಾರದ ವಕ್ರದೃಷ್ಟಿ ಬಿದ್ದಿದೆ.
ಮಾನ್ಯ @dineshgrao ಅವರೇ, ಪತಂಜಲಿ ಉತ್ಪನ್ನಗಳ ಮೇಲೆ… pic.twitter.com/TNo1uRXvKt
The blatant fraud committed by #BabaRamdev and his #Patanjali company is unforgivable.
— Dinesh Gundu Rao/ದಿನೇಶ್ ಗುಂಡೂರಾವ್ (@dineshgrao) April 10, 2024
He has brought disrepute to #Ayurveda and Indian System of Medicine.
This is what happens when you have Blind Faith.
Whether in Health, Business or Politics.
I’ve also instructed my Drugs… https://t.co/mhwp0Tafc2
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
234 held in anti-drug operation in Kerala
Thiruvananthapuram, Mar 15 (PTI): The Kerala police on Saturday said as part of its special drive to crack down on individuals suspected of drug trafficking, 234 people were arrested, and varying quantities of several deadly narcotics, including MDMA, were seized.
The State Police Media Centre (SPMC) stated that on March 14, as part of the drive, D-Hunt, authorities inspected 2,362 individuals suspected of drug trafficking and arrested 234 of them.
The operation was carried out across the state to identify and take strict legal action against those involved in the storage and distribution of banned drugs.
Police registered 222 cases related to the possession of various prohibited substances, according to a statement issued by the SPMC.
Additionally, authorities seized 0.0119 kg of MDMA, 6.171 kg of cannabis, and 167 cannabis 'beedis' from those arrested.
Operation D-Hunt is being jointly implemented by the Range-based NDPS Coordination Cell and District Police Chiefs under the leadership of State Anti-Narcotics Task Force Head and ADGP (Law and Order) Manoj Abraham, following the instructions of State Police Chief Dr Sheikh Darvesh Sahib, the statement said.
The SPMC also announced that a 24-hour Anti-Narcotics Control Room (9497927797) has been set up to receive information from the public regarding drug-related activities.
The details of individuals who contact this number will be kept confidential, it added.
Furthermore, the operation will continue in the coming days through sustained surveillance and the creation of a database of individuals regularly involved in drug-related activities and transactions.
